Medicare beneficiaries have long faced a burden of high prescription drug costs. But 2026 promises to be a year of meaningful relief: for the first time, Medicare is directly negotiating prices for high-cost drugs covered under Part D. PMC+3Centers for Medicare & Medicaid Services+3Centers for Medicare & Medicaid Services+3

This change stems from the Inflation Reduction Act, which empowered Medicare to bargain for “Maximum Fair Prices” (MFPs) on select drugs. Wikipedia+2Centers for Medicare & Medicaid Services+2

The negotiated prices will take effect on January 1, 2026, bringing lower costs for beneficiaries who rely on these medications. Centers for Medicare & Medicaid Services+2Centers for Medicare & Medicaid Services+2

While the list of drugs is still limited to 10 in this first negotiation cycle, it sets a precedent and opens the door for broader savings in future years.